Skip to main content
. 2021 Aug 24;26(11):e2002–e2012. doi: 10.1002/onco.13918

Figure 2.

Figure 2

Study timeline. Reinitiation within 90 days of the initial encounter discharge; note that there were no initial outpatient encounter irAEs for myocarditis, transverse myelitis, and toxic epidermal necrolysis and no initial inpatient encounter irAEs for acquired hemophilia.Abbreviations: AE, adverse event; HRU, health care resource utilization; ICI, immune checkpoint inhibitor; irAE, immune‐related adverse event.